Sep 30, 2019

Cogent Biosciences Q3 2019 Earnings Report

Total Revenue
$1.02M
Previous year: $2.04M
-50.1%
EPS
-$0.39
Previous year: -$0.34
+14.7%
Gross Profit
-$9.32M
Previous year: $2.04M
-555.9%
Cash and Equivalents
$45.9M
Previous year: $49.3M
-6.9%
Free Cash Flow
-$10.2M
Previous year: -$7.66M
+32.9%
Total Assets
$57.9M
Previous year: $94.8M
-38.9%

Cogent Biosciences

Cogent Biosciences

Cogent Biosciences Revenue by Segment